NCT05823961View on ClinicalTrials.gov

"PMCF Study to Evaluate Performance and Safety of CLHA-based Eyedrops Used to Improve Lacrimal Abnormalities"

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 10, 2022

Primary Completion Date

June 28, 2023

Study Completion Date

July 28, 2023

Conditions
Dry Eye DiseaseDry EyeKerato Conjunctivitis Sicca
Interventions
DEVICE

Cross-linked hyaluronic acid eye drops

Cross-linked hyaluronic acid (CLHA)-based eyedrops

Trial Locations (1)

95123

"Azienda Ospedaliero-Universitaria Policlinico G.Rodolico - San Marco", Catania

All Listed Sponsors
lead

C.O.C. Farmaceutici S.r.l.

INDUSTRY